GMP Compliance in Pharmaceutical Raw Material Sourcing
Understanding Good Manufacturing Practice requirements when procuring APIs, excipients, and intermediates — what documentation you need and how to audit your suppliers.
Dr. Priya Sharma
Head of Regulatory Affairs · May 12, 2026 · 7 min read
Good Manufacturing Practice (GMP) is the bedrock of pharmaceutical quality. For any manufacturer sourcing Active Pharmaceutical Ingredients (APIs), excipients, or intermediates from external suppliers, demonstrating GMP compliance throughout the supply chain is not optional — it is the line between a saleable batch and a regulatory recall.
This guide walks through the core documentation set you should request from every raw material supplier, the on-site checks that matter most during a vendor audit, and the common red flags that should give you pause before issuing a purchase order.
The Documentation Bundle
A compliant API supplier should provide each of the following as a matter of course — never as an afterthought when asked. If any item is missing or stale, treat it as a finding, not a forgivable oversight.
- Certificate of Analysis (COA) tied to the specific batch, with all monograph parameters tested and signed off by QA.
- Material Safety Data Sheet (MSDS / SDS) in the latest GHS-aligned format.
- Drug Master File (DMF) reference or Letter of Authorisation, where applicable.
- CEP / COS for European supply, or an equivalent regulatory dossier.
- GMP certificate from the local regulatory authority (CDSCO in India, FDA in the USA, EDQM in Europe).
- Stability data — at minimum 12 months real-time data plus accelerated study.
Auditing the Manufacturing Site
Documents are necessary but never sufficient. An on-site audit lets you verify that the systems described on paper are actually being followed on the shop floor. Pay particular attention to change-control records, deviation logs, and out-of-specification investigations — these tell you how the site behaves when things go wrong, which is the most honest signal of quality culture you will get.
Walk the warehouse. Check that incoming raw materials are quarantined, sampled, and only released to production after QA approval. Sit in on a batch-record review and trace one finished batch backwards to its inputs. If the paperwork tells a clean story but the operator on the line tells a different one, trust the operator.
Red Flags to Watch For
Suppliers who resist site visits, slow-walk document requests, or whose COA values are suspiciously identical across batches are signalling something. So are facilities where deviation rates appear too low — every real plant has deviations; the difference is how they are investigated and closed. A clean record with no documented learnings is usually a record of things not being looked at.
Sourcing the materials covered in this article?
Our team responds within 24 business hours with COA, MSDS, and pricing.
Written by
Dr. Priya Sharma
Head of Regulatory Affairs at Chemist India Ltd.
More from the Journal
Continue Reading
REACH Compliance for Chemical Exports to the European Union
Everything you need to know about Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) — who needs to comply, key timelines, and SVHC restrictions.
Mar 17, 2026 · 8 min read
Food Chemical Regulations: Navigating FSSAI and EU Standards
Food manufacturers sourcing preservatives, sweeteners, and emulsifiers must comply with both Indian FSSAI regulations and EU food additive directives. Here is a side-by-side comparison.
Jan 12, 2026 · 8 min read
India's Nutraceutical Market: Growth Drivers and Sourcing Opportunities
The Indian nutraceutical sector is growing at 15% CAGR. We explore the key ingredients in demand, regulatory landscape under FSSAI, and how manufacturers can build resilient supply chains.
Apr 28, 2026 · 9 min read